From the Summary: "The Food and Drug Administration (FDA) regulates the safety of foods (including dietary supplements), cosmetics, and radiation-emitting products; the safety and effectiveness of drugs, biologics (e.g., vaccines), and medical devices; and public health aspects of tobacco products. [...] FDA's 'total program level,' the amount that FDA can spend, is composed of discretionary appropriations from two different sources: annual appropriations (i.e., discretionary budget authority, or BA) and user fees paid by the regulated industry (e.g., drug manufacturers). In FDA's annual appropriation, Congress sets both the total amount of appropriated funds and the amount of user fees that the agency is authorized to collect and obligate for that fiscal year. [...] The Administration's FY2021 budget request for a 'total program level' of $6.044 billion would be an increase of $123 million (+2%) over the FY2020-enacted amount ($5.921 billion). This report will be updated with information on FDA funding for FY2021 once legislative action on appropriations for the new fiscal year is completed."
CRS Report for Congress, R44576
Congressional Research Service: https://crsreports.congress.gov/